Escitalopram is an antidepressant forming part of the class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It inhibits the reuptake of the neurotransmitter serotonin in the brain. Escitalopram improves the mood and reduces anxiety. It is used to treat depression and anxiety disorders (such as obsessive-compulsive disorders, panic disorders, post-traumatic stress disorder and social anxiety disorder).
Escitalopram and the benefit of DNA analysis
The rate at which escitalopram is processed within your body varies from one individual to another. This means that the efficacy and side effects of escitalopram can be predicted to some extent on the basis of your genes.
Preventive DNA analysis can therefore be an important tool in optimising your medication.
Escitalopram and the enzyme CYP2C19
Escitalopram is processed within the body primarily by the enzyme CYP2C19. The activity of this enzyme can vary considerably depending on your genetic predisposition, which means the efficacy of escitalopram and the risk of side effects can also differ from person to person.
Information about your genetic predisposition may therefore provide grounds for extra vigilance in relation to a treatment with escitalopram.
Read more about CYP2C19 enzyme »
Also known as
Escitalopram, Escitalopramum, Cipralex, Esertia, Lexapro